Downstaging
Downstaging of T stage
Only the pathological T stage of the Socazolimab + TP group differed significantly from that of the Placebo + TP group; no significant differences in the pathological N stage were detected between the two groups. Data for changes in stage are presented in Fig. Downstaging of T stage (A) and N stage (B) in the Socazolimab + TP and Placebo + TP groups after neoadjuvant treatment (TP: nab-paclitaxel/cisplatin). The upper plot shows the exact number of downstaging of T or N stage. The lower plot shows the T or N stage of each patient before the neoadjuvant treatment and after the surgery. Each column represents a patient enrolled in this study